Research Use Only. AOD-9604 is sold as a chemical reagent for in-vitro laboratory research. It is not a drug, supplement, or compounded preparation, and it is not for human or veterinary use. Wholesale Peptide Supply is not a pharmacy or compounding facility under 503A or 503B.
AOD-9604
AOD-9604 is a synthetic peptide fragment derived from the C-terminus of the somatotropin sequence, studied for its effects on lipolytic and anti-lipogenic pathways and β3-adrenergic signaling.
Wholesale Catalog
Available Doses
Wholesale pricing for AOD-9604 is provided by quote based on dose and order volume. Tell us what you need and your account manager will send a personalized quote — typically within 10 minutes during business hours.
Overview
AOD-9604 is a synthetic peptide fragment derived from the C-terminus of the somatotropin sequence, studied for its effects on lipolytic and anti-lipogenic pathways and β3-adrenergic signaling.
History
Developed late 1990s as a focused hGH fragment; advanced into early studies on metabolic effects, IGF-1, glucose tolerance, and immunogenicity.
Key Areas of Research
- Lipid pathways, β3-adrenergic dynamics
- Cartilage and connective tissue modeling
- Remodeling and viability
References
- Heffernan M. et al. (2001). hGH lipolytic fragment AOD9604. JCEM 86(4):1732–1742.
- Stier H. et al. (2013). Safety/tolerability of AOD9604. J Endocrinol Invest 36(5):360–365.
Research Use Only
All products are intended solely for laboratory research purposes and are not for human or animal consumption. Must be handled by qualified professionals.
Related Compounds
GLP-1 & Metabolic
Semaglutide
Semaglutide is a synthetic peptide analog that functions as a long-acting pathway agonist, structurally modified for extended half-life and improved target binding affinity. It is studied in preclinical and laboratory models for its ability to activate target pathways and modulate downstream molecular signaling associated with endocrine regulation.
View details →GLP-1 & Metabolic
Tirzepatide
Tirzepatide is a synthetic peptide that functions as a dual pathway agonist, designed as a once-weekly investigational compound studied in preclinical laboratory models for receptor-mediated signaling and modulation of downstream cascades.
View details →GLP-1 & Metabolic
Retatrutide
Retatrutide is a synthetic investigational peptide developed as a multi-pathway agonist, representing the next generation of metabolic research compounds. It activates multiple target receptor subtypes for broad systemic effects studied in preclinical models.
View details →